Author:
Nakanjako Damalie,Kiragga Agnes N.,Musick Beverly S.,Yiannoutsos Constantin T.,Wools-Kaloustian Kara,Diero Lameck,Oyaro Patrick,Lugina Emanuel,Ssali John C.,Kambugu Andrew,Easterbrook Philippa
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference45 articles.
1. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings;Gilks;Lancet,2006
2. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study. International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration (IeDEA-SA);Grimsrud;J Epidemiol Community Health,2015
3. Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa;Egger;Int J Epidemiol,2012
4. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population;Lewden;J Acquir Immune Defic Syndr,2007
5. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa;Lawn;BMC Infect Dis,2006